Antony Sguazzin

Stay informed with Antony Sguazzin’s coverage and analysis for Coins2Day.

Workers unload citrus at a juicing company in Brits, North West Province, South Africa

South Africa, the world’s second-largest exporter of oranges, lemons, and grapefruits, looks to peel back EU citrus restrictions it deems ‘not justified, proportionate or appropriate’

By Antony Sguazzin, Paul Vecchiatto, and others

Xi Jinping, Russian President Vladimir Putin, Brazilian President Jair Bolsonaro, India's Prime Minister Narendra Modi and South African President Cyril Ramaphosa

China, Russia and their BRICS allies have a ‘medium to long term ambition’ to create a dollar rival as a currency, official says

By Antony Sguazzin and Bloomberg

White Rhino. (Ceratotherium simum) Female with very long horn and calf. Lake Nakuru National Park Kenya. Dist. Localised: Southern and East Africa

The owner of a giant ranch is auctioning off his 2,000 white rhinos after he failed to legalize selling horns

By Antony Sguazzin and Bloomberg

An employee wears magnifying glasses to inspect and sort rough diamonds at the Lucara Diamond Corp. sales center at the Diamond Technology Park in Gaborone, Botswana, on Monday, Feb. 13, 2023. In 2019, Lucara unearthed the 1,758-carat Sewelo the worlds No. 2 stone after South Africas Cullinan diamond which was turned into a collection of Louis Vuitton jewelry. Photographer: Waldo Swiegers/Bloomberg via Getty Images

A De Beers rival is trying to revolutionize how giant diamonds worth millions of dollars are sold—and it’s working

By Antony Sguazzin and Bloomberg

Sir Elton John speaks at a press conference at the Saxon Hotel in Johannesburg on February 23, 2023. – US senators visiting South Africa to assess the impact of a mega US-funded HIV-AIDS scheme, on February 23, 2023 vowed to not curtail the programme despite Pretoria’s close ties with Russia.<br />
He accompanied a group of US senators visiting South Africa to mark 20 years since the launch of the President’s Emergency Plan for AIDS Relief, or PEPFAR.<br />
PEPFAR was launched in February 2003 by the then US president George W. Bush to combat the spread of AIDS in 15 of the hardest-hit areas of Africa and the Caribbean. (Photo by Paul Botes / AFP) (Photo by PAUL BOTES/AFP via Getty Images)

Elton John advocates for global AIDS relief program that has saved millions of lives: ‘My dying wish is to have this disease eliminated by 2030’

By Antony Sguazzin and Bloomberg

A technician uses a multi-channel pipette dropper to dispense material during Covid-19 antibody neutralization testing in a laboratory at the African Health Research Institute (AHRI) in Durban, South Africa, on Wednesday, Dec. 15, 2021. South Africas hospital admission rate as a percentage of new Covid-19 cases identified dropped sharply in the second week of the current infection wave driven by the omicron variant, compared with the same week of the third wave. Photographer: Waldo Swiegers/Bloomberg via Getty Images

New Omicron variants are so infectious that South Africa had a 5th wave even though 97% had antibody protection

By Antony Sguazzin and Bloomberg

A health worker prepares the Pfizer vaccine

Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn

By Josh Wingrove, James Paton, and others

A health worker administers a Covid-19 vaccine during a rural vaccination drive by Broadreach NGO in the Siyabuswa district of Mpumalanga, South Africa, on Wednesday, March 9, 2022. Excess deaths during the Covid-19 pandemic, seen as a more accurate way of measuring its impact than official statistics, climbed to 301,106 in the week ended March 5, according to South African Medical Research Council data. Photographer: Waldo Swiegers/Bloomberg via Getty Images

Prior COVID infections and today’s vaccines likely won’t help you avoid the new Omicron variants, author of new study says

By Antony Sguazzin and Bloomberg

A health worker administers a Covid-19 vaccine to a student during a rural vaccination drive by Broadreach NGO at Duduzile Secondary School in Mpumalanga, South Africa, on Wednesday, March 9, 2022. Excess deaths during the Covid-19 pandemic, seen as a more accurate way of measuring its impact than official statistics, climbed to 301,106 in the week ended March 5, according to South African Medical Research Council data. Photographer: Waldo Swiegers/Bloomberg via Getty Images

South African scientists have discovered 2 new Omicrons—and they’re already in Germany, Denmark and the U.K.

By Antony Sguazzin and Bloomberg

Elderly residents in wheelchairs are escorted to register for the Covid-19 vaccination program outside the Bonang Community Health Centre, in Brits, South Africa, on Friday, April 30, 2021. South Africa plans to buy Russia’s Sputnik V vaccines and shots developed by China’s Sinopharm Group Co. Ltd as it steps up efforts to tackle the coronavirus. Photographer: Waldo Swiegers/Bloomberg via Getty Images

COVID-19 may have killed 1 of every 200 South Africans, 3 times the official rate

By Antony Sguazzin and Bloomberg

COVID-19 boosters

COVID boosters do not provide protection against Omicron, study finds

By Antony Sguazzin and Bloomberg

South Africa Omicron study

Omicron may cut future severity of COVID and protect against the Delta variant, South Africa study finds

By Antony Sguazzin and Bloomberg

A woman receives a booster shot of the COVID-19 vaccine in Cape Town, South Africa, on Jan. 5, 2022. (Photo by Francisco Scarbar/Xinhua via Getty Images)

Omicron causes less severe illness even in the unvaccinated, South Africa study says

By Antony Sguazzin and Bloomberg

A health worker prepares doses of the Pfizer-BioNTech Covid-19 vaccine at Cape Flats Development Association (CAFDA) in the Egoli township of Cape Town, South Africa, on Tuesday, Nov. 30, 2021. South African scientists were last week the first to identify the new variant now known as omicron, and while symptoms have been described as mild, the exact risk from the new strain is still uncertain. Photographer: Dwayne Senior/Bloomberg via Getty Images

Pfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show

By Antony Sguazzin, Jason Gale, and others

A healthcare worker administers a SINOVAC Covid-19 vaccine on a minor during the Numolux/SINOVAC Paediatric Covid-19 Vaccine Clinical Trial at the Sefako Makgatho Health Sciences University in Pretoria, on September 10, 2021. – The primary objective of the study is to evaluate the efficacy of two doses of CoronaVac against confirmed symptomatic COVID-19 cases in children and adolescents aged 6 months to 17 years. Efficacy will also be evaluated against hospitalization and severe COVID-19 cases. The study worldwide will enroll 14 000 children and adolescents in various pediatric age group cohorts across 5 countries (South Africa, Chile, Philippines, Malaysia and Kenya). (Photo by Phill Magakoe / AFP) (Photo by PHILL MAGAKOE/AFP via Getty Images)

South Africa could become COVID ‘mutation factory’ because of large HIV-infected population, scientists say

By Rene Vollgraaff, Antony Sguazzin, and others

Web Analytics